Clinical Trial Update: Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of vorinostat for Niemann-Pick Disease Type C1 completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type C1

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Neimann-Pick Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-02-22